Origin of Aberrant Blood Pressure and Sympathetic Regulation in Diet-Induced Obesity

Hypertension

Volumn 68, Issue 2, 2016, Pages 491-500

  Lim, Kyungjoon ^a   Barzel, Benjamin ^a,b   Burke, Sandra L ^a   Armitage, James A ^a,b,c   Head, Geoffrey A ^a,b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c DEAKIN UNIVERSITY   (Australia)

Author keywords

hypertension; leptin; neuropeptide Y; obesity; SHU9119

Indexed keywords

ALPHA MELANOCORTIN STIMULATING HORMONE; HORMONE; HORMONE RECEPTOR BLOCKING AGENT; LEPTIN; LEPTIN RECEPTOR ANTAGONIST; LIPID; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; NEUROPEPTIDE Y; UNCLASSIFIED DRUG; ALPHA INTERMEDIN; INTERMEDIN; LEPTIN RECEPTOR; MELANOCORTIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET INDUCED OBESITY; DORSOMEDIAL HYPOTHALAMUS; ELECTRODE; HEART RATE; HYPERTENSION; HYPOTHALAMUS; LIPID DIET; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RABBIT MODEL; RENAL SYMPATHETIC NERVE ACTIVITY; RENAL SYSTEM PARAMETERS; SIGNAL TRANSDUCTION; ZONA INCERTA; ADRENERGIC SYSTEM; ADVERSE EFFECTS; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD PRESSURE; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; DRUG EFFECTS; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; METABOLISM; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RABBITS AND HARES;

ALPHA-MSH; ANIMALS; BLOOD PRESSURE; DIET, HIGH-FAT; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; HYPERTENSION; LEPTIN; MALE; MELANOCYTE-STIMULATING HORMONES; NEUROPEPTIDE Y; OBESITY; RABBITS; RECEPTORS, LEPTIN; RECEPTORS, MELANOCORTIN; SIGNAL TRANSDUCTION; SYMPATHETIC NERVOUS SYSTEM; VENTROMEDIAL HYPOTHALAMIC NUCLEUS;

EID: 84974721823     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.116.07461     Document Type: Article

References (46)

1. Dalton M, Cameron AJ, Zimmet PZ, Shaw JE, Jolley D, Dunstan DW, Welborn TA; AusDiab Steering Committee. Waist circumference, waisthip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med. 2003;254:555-563. doi: 10.1111/j.1365-2796.2003.01229.x.
2. Shibao C, Gamboa A, Diedrich A, Ertl AC, Chen KY, Byrne DW, Farley G, Paranjape SY, Davis SN, Biaggioni I. Autonomic contribution to blood pressure and metabolism in obesity. Hypertension. 2007;49:27-33. doi: 10.1161/01.HYP.0000251679.87348.05.
3. Prior LJ, Eikelis N, Armitage JA, Davern PJ, Burke SL, Montani JP, Barzel B, Head GA. Exposure to a high-fat diet alters leptin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension. 2010;55:862-868. doi: 10.1161/ HYPERTENSIONAHA.109.141119.
4. Head GA, Lim K, Barzel B, Burke SL, Davern PJ. Central nervous system dysfunction in obesity-induced hypertension. Curr Hypertens Rep. 2014;16:466. doi: 10.1007/s11906-014-0466-4.
5. Esler M. The sympathetic system and hypertension. Am J Hypertens. 2000;13(6 pt 2):99S-105S.
6. Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res. 2015;116:991-1006. doi: 10.1161/CIRCRESAHA.116.305697.
7. Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation. 1997;96:3423-3429. doi: 10.1161/01.CIR.96.10.3423.
8. Kassab S, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP. Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension. 1995;25(4 pt 2):893-897. doi: 10.1161/01.HYP.25.4.893.
9. Huang WC, Fang TC, Cheng JT. Renal denervation prevents and reverses hyperinsulinemia-induced hypertension in rats. Hypertension. 1998;32:249-254. doi: 10.1161/01.HYP.32.2.249.
10. Antic V, Kiener-Belforti F, Tempini A, Van Vliet BN, Montani JP. Role of the sympathetic nervous system during the development of obesityinduced hypertension in rabbits. Am J Hypertens. 2000;13(5 pt 1):556-559. doi: 10.1016/S0895-7061(99)00267-8.
11. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptormediated regional sympathetic nerve activation by leptin. J Clin Invest. 1997;100:270-278. doi: 10.1172/JCI119532.
12. Lambert E, Straznicky N, Sari CI, Eikelis N, Hering D, Head G, Dixon J, Esler M, Schlaich M, Lambert G. Dyslipidemia is associated with sympathetic nervous activation and impaired endothelial function in young females. Am J Hypertens. 2013;26:250-256. doi: 10.1093/ajh/hps016.
13. Rahmouni K, Morgan DA. Hypothalamic arcuate nucleus mediates the sympathetic and arterial pressure responses to leptin. Hypertension. 2007;49:647-652. doi: 10.1161/01.HYP.0000254827.59792.b2.
14. Rahmouni K, Correia ML, Haynes WG, Mark AL. Obesity-associated hypertension: new insights into mechanisms. Hypertension. 2005;45:9-14. doi: 10.1161/01.HYP.0000151325.83008.b4.
15. Williams G, Bing C, Cai XJ, Harrold JA, King PJ, Liu XH. The hypothalamus and the control of energy homeostasis: different circuits, different purposes. Physiol Behav. 2001;74:683-701. doi: 10.1016/S0031-9384(01)00612-6.
16. Cowley MA, Smart JL, Rubinstein M, Cerdán MG, Diano S, Horvath TL, Cone RD, Low MJ. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature. 2001;411:480-484. doi: 10.1038/35078085.
17. Barzel B, Lim K, Davern PJ, Burke SL, Armitage JA, Head GA. Central proopiomelanocortin but not neuropeptide Y mediates sympathoexcitation and hypertension in fat fed conscious rabbits. J Hypertens. 2016;34:464-473. doi: 10.1097/HJH.0000000000000811.
18. Mercer RE, Chee MJ, Colmers WF. The role of NPY in hypothalamic mediated food intake. Front Neuroendocrinol. 2011;32:398-415. doi: 10.1016/j.yfrne.2011.06.001.
19. Marsh AJ, Fontes MA, Killinger S, Pawlak DB, Polson JW, Dampney RA. Cardiovascular responses evoked by leptin acting on neurons in the ventromedial and dorsomedial hypothalamus. Hypertension. 2003;42:488-493. doi: 10.1161/01.HYP.0000090097.22678.0A.
20. Li P, Cui BP, Zhang LL, Sun HJ, Liu TY, Zhu GQ. Melanocortin. receptors in paraventricular nucleus modulate sympathetic outflow and blood pressure. Exp Physiol. 2013;98:435-443. doi: 10.1113/expphysiol.2012.067256.
21. Qi Y, Henry BA, Oldfield BJ, Clarke IJ. The action of leptin on appetiteregulating cells in the ovine hypothalamus: demonstration of direct action in the absence of the arcuate nucleus. Endocrinology. 2010;151:2106-2116. doi: 10.1210/en.2009-1283.
22. Young CN, Morgan DA, Butler SD, Mark AL, Davisson RL. The brain subfornical organ mediates leptin-induced increases in renal sympathetic activity but not its metabolic effects. Hypertension. 2013;61:737-744. doi: 10.1161/HYPERTENSIONAHA.111.00405.
23. Elmquist JK, Bjørbaek C, Ahima RS, Flier JS, Saper CB. Distributions of leptin receptor mRNA isoforms in the rat brain. J Comp Neurol. 1998;395:535-547.
24. Wang D, He X, Zhao Z, Feng Q, Lin R, Sun Y, Ding T, Xu F, Luo M, Zhan C. Whole-brain mapping of the direct inputs and axonal projections of POMC and AgRP neurons. Front Neuroanat. 2015;9:40. doi: 10.3389/fnana.2015.00040.
25. Vander Tuig JG, Knehans AW, Romsos DR. Reduced sympathetic nervous system activity in rats with ventromedial hypothalamic lesions. Life Sci. 1982;30:913-920.
26. Harlan SM, Morgan DA, Agassandian K, Guo DF, Cassell MD, Sigmund CD, Mark AL, Rahmouni K. Ablation of the leptin receptor in the hypothalamic arcuate nucleus abrogates leptin-induced sympathetic activation. Circ Res. 2011;108:808-812. doi: 10.1161/CIRCRESAHA.111.240226.
27. Lindberg D, Chen P, Li C. Conditional viral tracing reveals that steroidogenic factor 1-positive neurons of the dorsomedial subdivision of the ventromedial hypothalamus project to autonomic centers of the hypothalamus and hindbrain. J Comp Neurol. 2013;521:3167-3190. doi: 10.1002/cne.23338.
28. Lim K, Burke SL, Head GA. Obesity-related hypertension and the role of insulin and leptin in high-fat-fed rabbits. Hypertension. 2013;61:628-634. doi: 10.1161/HYPERTENSIONAHA.111.00705.
29. Simonds SE, Pryor JT, Ravussin E, et al. Leptin mediates the increase in blood pressure associated with obesity. Cell. 2014;159:1404-1416. doi: 10.1016/j.cell.2014.10.058.
30. Enriori PJ, Sinnayah P, Simonds SE, Garcia Rudaz C, Cowley MA. Leptin action in the dorsomedial hypothalamus increases sympathetic tone to brown adipose tissue in spite of systemic leptin resistance. J Neurosci. 2011;31:12189-12197. doi: 10.1523/JNEUROSCI.2336-11.2011.
31. Burke SL, Head GA. Method for in vivo calibration of renal sympathetic nerve activity in rabbits. J Neurosci Methods. 2003;127:63-74. doi: 10.1016/S0165-0270(03)00121-3.
32. Korner PI, Badoer E, Head GA. Cardiovascular role of the major noradrenergic cell groups in the rabbit: analysis based on 6-hydroxydopamine-induced transmitter release. Brain Res. 1987;435:258-272. doi: 10.1016/0006-8993(87)91609-X.
33. Ambati S, Duan J, Choi YH, Hartzell DL, Della-Fera MA, Baile CA. ICV vs. VMH injection of leptin: comparative effects on hypothalamic gene expression. Behav Brain Res. 2009;196:279-285. doi: 10.1016/j.bbr.2008.09.014.
34. Montanaro MS, Allen AM, Oldfield BJ. Structural and functional evidence supporting a role for leptin in central neural pathways influencing blood pressure in rats. Exp Physiol. 2005;90:689-696. doi: 10.1113/ expphysiol.2005.030775.
35. Tao YX. The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology. Endocr Rev. 2010;31:506-543. doi: 10.1210/er.2009-0037.
36. da Silva AA, do Carmo JM, Wang Z, Hall JE. The brain melanocortin system, sympathetic control, and obesity hypertension. Physiology (Bethesda). 2014;29:196-202. doi: 10.1152/physiol.00061.2013.
37. Rahmouni K, Haynes WG, Mark AL. Cardiovascular and sympathetic effects of leptin. Curr Hypertens Rep. 2002;4:119-125.
38. Grassi G. Sympathetic neural activity in hypertension and related diseases. Am J Hypertens. 2010;23:1052-1060. doi: 10.1038/ajh.2010.154.
39. Haynes WG, Morgan DA, Djalali A, Sivitz WI, Mark AL. Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension. 1999;33(1 pt 2):542-547. doi: 10.1161/01. HYP.33.1.542.
40. Kuo JJ, da Silva AA, Tallam LS, Hall JE. Role of adrenergic activity in pressor responses to chronic melanocortin receptor activation. Hypertension. 2004;43:370-375. doi: 10.1161/01.HYP.0000111836.54204.93.
41. Fuxe K, Agnati LF, Härfstrand A, Zini I, Tatemoto K, Pich EM, Hökfelt T, Mutt V, Terenius L. Central administration of neuropeptide Y induces hypotension bradypnea and EEG synchronization in the rat. Acta Physiol Scand. 1983;118:189-192. doi: 10.1111/j.1748-1716.1983.tb07261.x.
42. Cassaglia PA, Shi Z, Li B, Reis WL, Clute-Reinig NM, Stern JE, Brooks VL. Neuropeptide Y acts in the paraventricular nucleus to suppress sympathetic nerve activity and its baroreflex regulation. J Physiol. 2014;592:1655-1675. doi: 10.1113/jphysiol.2013.268763.
43. Chao PT, Yang L, Aja S, Moran TH, Bi S. Knockdown of NPY expression in the dorsomedial hypothalamus promotes development of brown adipocytes and prevents diet-induced obesity. Cell Metab. 2011;13:573-583. doi: 10.1016/j.cmet.2011.02.019.
44. Lee SJ, Verma S, Simonds SE, Kirigiti MA, Kievit P, Lindsley SR, Loche A, Smith MS, Cowley MA, Grove KL. Leptin stimulates neuropeptide Y and cocaine amphetamine-regulated transcript coexpressing neuronal activity in the dorsomedial hypothalamus in diet-induced obese mice. J Neurosci. 2013;33:15306-15317. doi: 10.1523/JNEUROSCI.0837-13.2013.
45. Pronchuk N, Colmers WF. NPY presynaptic actions are reduced in the hypothalamic mpPVN of obese (fa/fa), but not lean, Zucker rats in vitro. Br J Pharmacol. 2004;141:1032-1036. doi: 10.1038/sj.bjp.0705699.
46. Beck B, Richy S, Dimitrov T, Stricker-Krongrad A. Opposite regulation of hypothalamic orexin and neuropeptide Y receptors and peptide expressions in obese Zucker rats. Biochem Biophys Res Commun. 2001;286:518-523. doi: 10.1006/bbrc.2001.5420.